CROM Group is headquartered in Verona, Italy, and since commencing operations has grown steadily and now operates subsidiaries in Germany, Poland, Ukraine, Russia, the United Kingdom and the United States of America. These subsidiaries, and the company's own staff located in many other European countries, provide an established infrastructure through which CROM Group is active across the whole of Europe and the USA .
Whilst CROM Group routinely works with many of the largest multinational pharmaceutical companies, it remains a mid-sized organisation and offers an adaptable structure to its sponsors who quickly establish direct contacts with the project team, including senior management. The group's proactive approach includes ‘Quality by Design’ – a determination to review all aspects of operations, including those of each single project, with a view to preventing problems rather than relying solely on the ability to react to issues when they arise.
The heart of CROM Group is a team of more than 170 professional staff, all of whom have substantial experience in multinational clinical trials. Highly qualified medical experts and project managers supervise and coordinate all clinical projects ensuring that a Sponsor’s trials are conducted to the highest quality standard, on time and to budget. Because CROM Group successfully retains its staff, the entire project team typically remains constant throughout the lifespan of each study. The team is also experienced in conducting ‘rescue studies’ where the performance of other CROs has not satisfied the Sponsor.
Quality management and quality assurance are kept under constant review and are assiduously implemented by CROM Group. Quality assurance is guaranteed through the integrated, certified quality system ISO 9001 first achieved in 2002 when few competitor companies had considered such accreditation important. The quality system is revised quarterly and thoroughly reviewed every two years by an external and independent auditor.
Central to the success of any clinical trial is appropriate site selection. Having completed over 500 trials, CROM Group has close links to a large number of high quality, motivated investigational sites with high recruitment potential. The company's established presence ‘on the ground’ in these locations ensures that feasibility analyses are detailed and accurate, allowing Sponsors to select countries and sites optimally to meet their trial timelines.
CROM Group is convinced that technological innovation is one of the key factors for success. Continuous investments in state of the art technology (such as CTMS, IVRS, EDC, electronic document management, etc.) underline its commitment.
Perhaps the most pertinent indicator of the level of satisfaction experienced by Sponsors who choose to work with CROM Group is the high number of Sponsors who return to CROM Group with their projects time and again. The company is proud of this level of repeat business and hopes that this encourages you to find out more about us. |
